等待开盘 08-18 09:30:00 美东时间
-2.670
-2.34%
今日重点评级关注:HC Wainwright & Co.:维持Innate Pharma"买入"评级,目标价从5美元升至7美元;HC Wainwright & Co.:维持Immix Biopharma"买入"评级,目标价从20美元升至25美元
08-11 11:45
Needham analyst Mayank Tandon maintains Agilysys (NASDAQ:AGYS) with a Buy and raises the price target from $130 to $135.
08-10 17:20
今日重点评级关注:HC Wainwright & Co.:维持Q32 Bio"买入"评级,目标价从13美元升至36美元;Chardan Capital:维持ProMIS Neurosciences"买入"评级,目标价从20美元升至33美元
07-29 11:37
Agilysys Inc (NASDAQ:AGYS) reported better-than-expected earnings for the second quarter on Monday. The company posted quarterly earnings of 49 cents per share which beat the analyst consensus estimate of 40 cents per share. The company reported quarterly sales of $87.677 million which beat the anal...
07-28 20:02
Piper Sandler analyst Billy Fitzsimmons maintains Agilysys (NASDAQ:AGYS) with a Overweight and raises the price target from $110 to $120.
07-28 17:08
华盛资讯7月28日讯,阿吉赛斯公布2026财年Q2业绩,公司Q2营收0.88亿美元,同比增长14.4%,归母净利润0.09亿美元,同比增长83.9%。
07-28 04:59
华盛资讯7月28日讯,阿吉赛斯公布2026财年Q2业绩,公司Q2营收0.88亿美元,同比增长14.4%,归母净利润0.09亿美元,同比增长83.9%。
07-28 04:48
Agilysys (NASDAQ:AGYS) raises FY2027 sales outlook from $365.000 million-$370.000 million to $368.000 million-$373.000 million vs $367.767 million estimate.
07-28 04:07
Agilysys (NASDAQ:AGYS) reported quarterly earnings of $0.49 per share which beat the analyst consensus estimate of $0.40 by 22.5 percent. This is a 48.48 percent increase over earnings of $0.33 per share from the same period last year. The company reported quarterly sales of $87.677 million which be...
07-28 04:07
Galaxy Gaming (GLXZ) has appointed Anand Singh as chief technology officer, effective July 6, 2026. Singh brings more than two decades of experience driving engineering excellence and product innovati...
07-14 22:22